Increased reduction of dimethylarginines and lowered interdialytic blood pressure by the use of biocompatible membranes
- 1 February 2001
- journal article
- research article
- Published by Elsevier in Kidney International
- Vol. 59, S19-S24
- https://doi.org/10.1046/j.1523-1755.2001.59780019.x
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Factors associated with inadequate blood pressure control in hypertensive hemodialysis patientsAmerican Journal of Kidney Diseases, 1999
- Hemodialysis Hypotension: Interaction of Inhibitors, iNOS, and the Interdialytic PeriodThe American Journal of the Medical Sciences, 1999
- Concentration of dimethyl-L-arginine in the plasma of patients with end-stage renal failureNephrology Dialysis Transplantation, 1996
- Nitric oxide: mediator, murderer, and medicineThe Lancet, 1994
- The L-Arginine-Nitric Oxide PathwayNew England Journal of Medicine, 1993
- Evidence for high risk of cerebral hemorrhage in chronic dialysis patientsKidney International, 1993
- Morbidity and Mortality Due to Hypertension in Patients With Renal FailureAmerican Journal of Kidney Diseases, 1993
- Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failureThe Lancet, 1992
- Effect of in vivo contact between blood and dialysis membranes on protein catabolism in humansKidney International, 1990
- Measurement of free amino acids in human biological fluids by high-performance liquid chromatographyJournal of Chromatography A, 1984